Literature DB >> 36200027

Identification of potential core genes and miRNAs in pediatric ACC via bioinformatics analysis.

Chunyan Fang1, Yulong Ye2, Fangyue Wang1, Yifeng Shen1, Yaodong You1.   

Abstract

Pediatric adrenocortical carcinomas (ACC) are rare aggressive neoplasms with heterogeneous prognosis, and often produce a most lethal malignant tumor, whereas its aetiology is still unclear. The aim of the present study was to identify the factors responsible for the development of pediatric ACC, a better understanding of the disease, and investigate new molecular biomarkers and therapeutic targets. To identify the key genes and miRNAs linked to pediatric ACC, as well as their potential molecular mechanisms, the GSEGSE75415 and GSE169253 microarray datasets were analyzed. A total of 329 differentially produced genes (DEGs) and 187 differentially produced miRNAs (DEMs) were obtained after analyzing the GSEGSE75415 and GSE169253 datasets, respectively. Next, 3,359 genes were obtained by overlapping the target mRNAs of DEMs. Following protein-protein interaction network and Gene Ontology analysis, the ten nodes with the highest degrees were screened as hub genes. Among them, the highly expressed hub genes, MAPK1 and EP300, were associated with a worse overall survival. Additionally, hsa-miR-376, hsa-miR-148, hsa-miR-139, and hsa-miR-1305 were strongly associated with poorer survival. We proposed that the hub genes (MAPK1, EP300, hsa-miR-376, hsa-miR-148, hsa-miR-139, and hsa-miR-1305) may have a definite impact on cellular proliferation and migration in adrenocortical tumors. The roles of these hub genes in adrenocortical tumors may provide novel insight to improve the diagnosis and treatment of patients with pediatric ACC. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  DEGs; hub genes; microRNAs; pediatric adrenocortical carcinomas; prognosis

Year:  2022        PMID: 36200027      PMCID: PMC9437998          DOI: 10.5582/irdr.2022.01077

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  29 in total

1.  Mutations truncating the EP300 acetylase in human cancers.

Authors:  S A Gayther; S J Batley; L Linger; A Bannister; K Thorpe; S F Chin; Y Daigo; P Russell; A Wilson; H M Sowter; J D Delhanty; B A Ponder; T Kouzarides; C Caldas
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

2.  miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

Authors:  Daniela Cimino; Cristiano De Pittà; Francesca Orso; Matteo Zampini; Silvia Casara; Elisa Penna; Elena Quaglino; Marco Forni; Christian Damasco; Eva Pinatel; Riccardo Ponzone; Chiara Romualdi; Cathrin Brisken; Michele De Bortoli; Nicoletta Biglia; Paolo Provero; Gerolamo Lanfranchi; Daniela Taverna
Journal:  FASEB J       Date:  2012-12-11       Impact factor: 5.191

3.  miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).

Authors:  Guo-Long Liu; Xia Liu; Xiao-Bin Lv; Xiao-Pai Wang; Xi-Sheng Fang; Yi Sang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 4.  Targeting the MAPK Pathway in KRAS-Driven Tumors.

Authors:  Matthias Drosten; Mariano Barbacid
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

Review 5.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 6.  Oncogenes in melanoma: an update.

Authors:  Manfred Kunz
Journal:  Eur J Cell Biol       Date:  2013-12-31       Impact factor: 4.492

7.  Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells.

Authors:  Jun-Feng Hao; Pei Chen; He-Yi Li; Ya-Jing Li; Yu-Ling Zhang
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

Review 8.  Adenosine-to-inosine RNA editing in neurological development and disease.

Authors:  Yuxi Yang; Shunpei Okada; Masayuki Sakurai
Journal:  RNA Biol       Date:  2021-01-06       Impact factor: 4.652

9.  Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.

Authors:  Daixing Hu; Li Jiang; Shengjun Luo; Xin Zhao; Hao Hu; Guozhi Zhao; Wei Tang
Journal:  J Transl Med       Date:  2020-04-07       Impact factor: 5.531

Review 10.  Adrenocortical carcinoma: a literature review.

Authors:  Ammu Thampi; Ekta Shah; Ghada Elshimy; Ricardo Correa
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.